Lin TH,Voon WC,Yen HW,et al.Lercanidipine andlosartan effects on blood pressure and fibrinolyticparameters. Kaohsiung J Mde Sci . 2006Kaohsiung J., Tsung L., Wen V., Hsueh Y., Chih H., Homing S., Wenter L., Sheng S. 2006. Lercanidipine and losartan effects on blood pressure and...
ABSTRACT Aim: To compare the effects of losartan and captopril on essential hypertension. Methods: Fifty nine patients were treated with losartan,50 mg～100 mg/d;fifty six patients were treated with captopril 25 mg～75 mg/d for six weeks for comparison.Blood pressure were monitored ,blood lipid...
2006. Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters. Taiwan. 22(4): 177-189.Lin TH, Voon WC, Yen HW, et al. Lercanidipine and losar- tan effects on blood pressure and fibrinolytic parameters. Kaohsiung J Med Sci. 2006;22:177-83....
Pharmacokinetic parameters after multiple doses of losartan (average dose 0.7 mg/kg, range 0.36 to 0.97 mg/kg) as a tablet to 25 hypertensive patients aged 6 to 16 years are shown in Table 4 below. Pharmacokinetics of losartan and its active metabolite were generally similar across the studied...
Parameters tested after fourteen days of treatment were creatinine clearance, protein excretion rate, glomerular volume, renal ACE1 and ACE2 protein expression. Data were compared using One-way-ANOVA followed by Tukey’s HSD post hoc test. Results Thyroxine caused glomerular hypertrophy and proteinuria...
Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes OBJECTIVE: The BENIFICIARY (BENIcar safety and efFICacy evaluatIon: An open-label, single-ARm, titration study in patients with hypertension and tYpe 2 dia...
While these parameters were similar in the dialysis groups, only BPs in losartan group were higher. After 16 weeks, BPs, Socolow-Lyon and Cornell voltages values in losartan group significantly decreased but not in the HD control group. Whereas maximum QT and QTc, QTd, QTcd, heart rate and...
(ACR) and basic parameters. Compared with control mice, DKD mice have heavier weight, higher fasting blood glucose, more significantly increased urinary ACR (Fig.1A, B, D and E), and slightly increased serum creatinine levels, but not statistically significant (Fig.1C). After treatment with ...
A fixed dose combination of losartan, an angiotensin receptor blocker and amlodipine, a calcium channel blocker, can potentially provide complementary mechanism of action to improve blood pressure control and clinical outcomes. The current study was conducted to compare the pharmacokinetics of a new comb...
Losartan/HCTZ is an effective combination therapy, lowering blood pressure (BP) to a greater extent than losartan or HCTZ alone in patients with hypertension. Other ARB/HCTZ fixed-dose combinations generally lowered BP to a greater extent than losartan/HCTZ in patients with hypertension, although wh...